(Press-News.org) Scientists from The University of Manchester have identified a way to sensitise cancer cells to chemotherapy - making them more open to treatment.
The study published today in Cell Reports, could pave the way for the development of drugs to target cells that have become resistant to treatment.
The research team made the discovery whilst exploring the possible mechanisms behind resistance to chemotherapy drugs like Paclitaxel, often used to treat breast and colon cancer.
Dr Andrew Gilmore, who led the research team at The University of Manchester, is part of both the Wellcome Trust Centre for Cell-Matrix Research and also the Manchester Cancer Research Centre.
He said: "Cells replicate and divide through a process known as mitosis. This process is carefully controlled and if any mistake is made during normal division then the cell undergoes apoptosis – otherwise known as controlled cell death.
"Failure of cells to complete mitosis correctly can be the start of cancer. We wanted to understand how this failure – delay of cell division - activates apoptosis, and why some cancer cells may be able to avoid being killed."
Cancer cells replicate rapidly, and chemotherapy drugs such as paclitaxel target mitosis as a way to kill these quickly dividing cells. But cancer cells can develop resistance to the drugs.
The researchers found a particular protein known as 'Bid' in colon cancer cells, and looked at what happened when Bid was switched on.
Their results show that Bid is turned on as cells prepare to divide. This primes the cells to die if cell division takes too long. Cancer cells that were resistant to chemotherapy still turned Bid on, but went through mitosis too quickly for it to kill the cell. However, these resistant cells could be made to die by directly targeting the part of the cell where Bid works.
"Our findings demonstrate that Bid plays a central role in mitosis-related cell death. This opens up new areas of research into drugs that might be able to kill cancer cells that have become resistant to chemotherapy. This could eventually be of huge benefit in a clinical setting and help patients who suffer from advanced stages of colon cancer," added Dr Gilmore.
INFORMATION: END
Scientists find way to target cells resistant to chemo
2014-04-24
ELSE PRESS RELEASES FROM THIS DATE:
New type of protein action found to regulate development
2014-04-24
Johns Hopkins researchers report they have figured out how the aptly named protein Botch blocks the signaling protein called Notch, which helps regulate development. In a report on the discovery, to appear online April 24 in the journal Cell Reports, the scientists say they expect the work to lead to a better understanding of how a single protein, Notch, directs actions needed for the healthy development of organs as diverse as brains and kidneys.
The Johns Hopkins team says their experiments show that Botch uses a never-before-seen mechanism, replacing one chemical group ...
Researchers discover new genetic brain disorder in humans
2014-04-24
A newly identified genetic disorder associated with degeneration of the central and peripheral nervous systems in humans, along with the genetic cause, is reported in the April 24, 2014 issue of Cell.
The findings were generated by two independent but collaborative scientific teams, one based primarily at Baylor College of Medicine and the Austrian Academy of Sciences, the other at the University of California, San Diego School of Medicine, the Academic Medical Center (AMC) in the Netherlands and the Yale University School of Medicine.
By performing DNA sequencing ...
Scientists reprogram blood cells into blood stem cells in mice
2014-04-24
BOSTON (April 24, 2014)—Researchers at Boston Children's Hospital have reprogrammed mature blood cells from mice into blood-forming hematopoietic stem cells (HSCs), using a cocktail of eight genetic switches called transcription factors. The reprogrammed cells, which the researchers have dubbed induced HSCs (iHSCs), have the functional hallmarks of HSCs, are able to self-renew like HSCs, and can give rise to all of the cellular components of the blood like HSCs.
The findings mark a significant step toward one of the most sought-after goals of regenerative medicine: the ...
To mark territory or not to mark territory: Breaking the pheromone code
2014-04-24
LA JOLLA, CA— April 24, 2014 —A team led by scientists at The Scripps Research Institute (TSRI) has deciphered the surprisingly versatile code by which chemical cues help trigger some of the most basic behaviors in mice.
The findings shed light on the evolution of mammalian behaviors—which include human behaviors—and their underlying brain mechanisms.
"How does an individual respond differently to the environment based on experience? How does it distinguish itself from others? These are some of the fundamental questions that a study like this one helps us address," ...
Genetic legacy from the Ottoman Empire: Single mutation causes rare brain disorder
2014-04-24
An international team of researchers have identified a previously unknown neurodegenerative disorder and discovered it is caused by a single mutation in one individual born during the Ottoman Empire in Turkey about 16 generations ago.
The genetic cause of the rare disorder was discovered during a massive analysis of the individual genomes of thousands of Turkish children suffering from neurological disorders.
"The more we learn about basic mechanisms behind rare forms of neuro-degeneration, the more novel insights we can gain into more common diseases such as Alzheimer's ...
Oops! Researchers find neural signature for mistake correction
2014-04-24
Culminating an 8 year search, scientists at the RIKEN-MIT Center for Neural Circuit Genetics captured an elusive brain signal underlying memory transfer and, in doing so, pinpointed the first neural circuit for "oops" ? the precise moment when one becomes consciously aware of a self-made mistake and takes corrective action.
The findings, published in Cell, verified a 20 year old hypothesis on how brain areas communicate. In recent years, researchers have been pursuing a class of ephemeral brain signals called gamma oscillations, millisecond scale bursts of synchronized ...
Large-scale identification and analysis of suppressive drug interactions
2014-04-24
TORONTO – Baker's yeast is giving scientists a better understanding of drug interactions, which are a major cause of hospitalization and illness world-wide.
When two or more medications are taken at the same time, one can suppress or enhance the effectiveness of the other. Similarly, one drug may magnify the toxicity of another. These types of interactions are a major cause of illness and hospitalization. However, there are severe practical limits on the practical scope of drug studies in humans. Limits come in part from ethics and in part from the staggering expense. ...
Skin layer grown from human stem cells could replace animals in drug and cosmetics testing
2014-04-24
An international team led by King's College London and the San Francisco Veteran Affairs Medical Center (SFVAMC) has developed the first lab-grown epidermis – the outermost skin layer - with a functional permeability barrier akin to real skin. The new epidermis, grown from human pluripotent stem cells, offers a cost-effective alternative lab model for testing drugs and cosmetics, and could also help to develop new therapies for rare and common skin disorders.
The epidermis, the outermost layer of human skin, forms a protective interface between the body and its external ...
Scripps Research Institute scientists find new point of attack on HIV for vaccine development
2014-04-24
LA JOLLA, CA— April 24, 2014 —A team led by scientists at The Scripps Research Institute (TSRI) working with the International AIDS Vaccine Initiative (IAVI) has discovered a new vulnerable site on the HIV virus. The newly identified site can be attacked by human antibodies in a way that neutralizes the infectivity of a wide variety of HIV strains.
"HIV has very few known sites of vulnerability, but in this work we've described a new one, and we expect it will be useful in developing a vaccine," said Dennis R. Burton, professor in TSRI's Department of Immunology and Microbial ...
Three-banded panther worm debuts as a new model in the study of regeneration
2014-04-24
CAMBRIDGE, Mass. (April 24, 2014) – Closely resembling plump grains of wild rice set in motion, the three-banded panther worms swimming in disposable containers in Whitehead Institute Member Peter Reddien's lab hardly seem like the next big thing in regeneration. And yet, these little-studied organisms possess the ability to regenerate any part of their bodies and are amenable to molecular studies in the lab, making them a valuable addition to a field keen on understanding how mechanisms controlling regeneration have evolved over millennia and how they might be activated ...